ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pivotal phase III trial launched in recurrent ovarian cancer
March 26, 2019INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer… -
APRO collaborates with Pivotal on three ISTs for genitourinary cancers
July 12, 2018Spanish pharmaceutical cooperative Associació per a la Recerca Oncológia (APRO) has announced a partnership with European contract research organisation (CRO) Pivotal on three investigator sponsored trials (ISTs) of two drugs for patients with genitourina -
Pivotal bioVenture Partners debuts $150M China-focused biotech fund
May 29, 2018The Nan Fung Group’s venture capital firm Pivotal bioVenture Partners has raised a $150 million venture fund to help early-stage life science companies located within China.
Pharma Sources Insight January 2025
